Rating History for Corcept Therapeutics (CORT) by Canaccord Genuity
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/27/2022 | Edward Nash | New Coverage | Buy (N/A) |
34.00 (N/A) |
23.80 (24.35) |
2.31% | Details |
 |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/27/2022 | Edward Nash | New Coverage | Buy (N/A) |
34.00 (N/A) |
23.80 (24.35) |
2.31% | Details |
|
|||||||
